Pierre-yves Desprez PhD

Dr. Pierre-Yves Desprez joined the University of California at Berkeley after completion of his doctoral thesis at the University of Lyon in France. Dr. Desprez has been a Principal Investigator at the California Pacific Medical Center Research Institute in San Francisco since 1996. The laboratory was the first one to show that the transcriptional regulators, Id genes and proteins, were promising targets for the suppression of invasive and metastatic cancers. Recently, the discovery by Dr. Desprez and his colleague Dr. McAllister that a cannabinoid compound represented the first non-toxic agent that decreased Id-1 expression, and consequently breast tumor aggressiveness and metastasis, was reported worldwide by several news agencies.